West Hollywood, CANCT07107841Now EnrollingIRB Ready

Androgenic Alopecia Clinical Trial in West Hollywood, CA

Access cutting-edge androgenic alopecia treatment through this clinical trial at a research site in West Hollywood. Study-provided care at no cost to qualified participants.

Sponsored by Acorn Biolabs Inc.

Quick Self-Assessment

See if you qualify for this West Hollywood location

Preparing your pre-screening questions…

Expert Care in West Hollywood

Access androgenic alopecia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related androgenic alopecia treatment provided free

Apply for This West Hollywood Location

Check if you qualify for this androgenic alopecia clinical trial in West Hollywood, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to West Hollywood

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit West Hollywood site if eligible
  4. 4Begin participation

About This Androgenic Alopecia Study in West Hollywood

(SINGLE SITE Study) The purpose of this clinical trial is to evaluate the safety and efficacy of the use of an autologous hair follicle derived secretome for androgenous alopecia. The secretome will be injected into the scalp at baseline, and days 30, 90, 180, 270 and 365. Hair growth will be quantitatively measured for density and thickness. PROs will also be collected from participants. This study will be run at a SINGLE SITE.

Sponsor: Acorn Biolabs Inc.

Who Can Participate

Inclusion Criteria

SUBJECTS MUST BE ON A STABLE COURSE OF MINOXIDIL (ORAL OR TOPICAL) AND/OR 5-ALPHA REDUCTASE INHIBITORS. THEY MUST HAVE BEEN ON THE SAME 5-ALPHA REDUCTASE INHIBITOR FOR ≥12 MONTHS PRIOR TO BASELINE.
FEMALE SUBJECTS MUST NOT BE ON HAIR GROWTH MEDICATIONS OR TOPICALS FOR ≥6 MONTHS PRIOR TO BASELINE.
TESTOSTERONE REPLACEMENT THERAPY (TRT) IN ANY FORM (E.G. DEPO-, INJECTABLE, TOPICAL, PATCHES, NASAL GEL, ORAL, PELLET ETC.) IS ALLOWED AS LONG AS SUBJECT HAS BEEN ON A STABLE COURSE (IN THE OPINION OF THE INVESTIGATOR) OF TRT FOR ≥12 MONTHS.
Biological sex: Male and Female (up to n=20 males and up to n=10 females will be in each arm for a total of up to n=40 males and up to n=20 females)
Age: ≥18 - 65 years
Subjects with Androgenic alopecia
No intention to start new hair growth medications and no intention to change the dosage or usage of minoxidil or 5-alpha reductase inhibitors until the end of their participation in the trial.
Competent and willing to provide written, informed consent to participate in all study activities.
Willing and able to tolerate multiple injections of the study product.
Must be able to attend all study related clinical visits.
Willing to maintain the same hair style as at the Screening Visit for the duration of the study.
Must be willing to have small (diameter similar to a pencil lead) UV (invisible) or red colored tattoo dots applied to scalp (up to 5) and touch up tattoos if necessary. UV tattoo dots only show under black light. Subjects will chose UV or red.

Exclusion Criteria

Subjects with clinical diagnosis of alopecia areata or other non-androgenic forms of alopecia.
Active skin disease (Psoriasis or severe seborrheic dermatitis) of the scalp
Scalp infection
Severe active systemic infection
Cuts or abrasions on the scalp
History of surgical hair restoration in the last 12 months.
Current or recent (within last 5 years) malignancy (except basal cell and squamous cell skin cancers)
History of systemic chemotherapy or radiation
History of thyroid dysfunction
History of autoimmune disorder (specifically Graves disease, Hashimoto thyroiditis, or systemic lupus erythematosus)
Continuous/daily use of nonsteroidal anti-inflammatory or Vitamin E, unless discontinued within 7 days before 1st treatment and only used as needed through the trial period.
Use of any medications that potentially cause drug-induced hair loss (e.g., depo-testosterone, haloperidol, methotrexate, methylprednisolone, prednisone, testosterone, divalproex sodium) within the last 3 months.
Known allergy or sensitivity to tattoo ink.
Current anticoagulant therapy (heparins; factor Xa inhibitors; direct agents such dabigatran, rivaroxaban, apixaban, edoxaban and betrixaban; warfarin/coumarins)
Significant tendency to develop keloids or hypertrophic scarring
Subjects unable to communicate with the investigator and staff
Any health condition that in the investigator's opinion should preclude participation in this study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in West Hollywood?

Yes, this clinical trial (NCT07107841) has an active research site in West Hollywood, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Androgenic Alopecia Treatment Options in West Hollywood, CA

If you're searching for androgenic alopecia treatment options in West Hollywood, CA, this clinical trial (NCT07107841) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our West Hollywood research site is actively enrolling participants for this clinical trial. You'll receive care from experienced androgenic alopecia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all androgenic alopecia clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in West Hollywood, CA

See all pulmonary embolism clinical trials recruiting in West Hollywood — not just this study.

Browse Pulmonary Embolism Trials in West Hollywood →

Browse More Trials by Condition

Pulmonary Embolism TrialsAlopecia TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in West Hollywood?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · West Hollywood, CA